Search

everythinglearnresearchcommunity

for

Search:↓

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Hair follicle stem cells help heal wounds by turning certain immune cells into ones that reduce inflammation.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

ILC1-like cells can independently cause alopecia areata.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.